BCL2L1 and hepatocellular carcinoma: The IL-6/Stat3 signaling promotes HCC progression through inhibiting apoptosis by inducing the expression of anti-apoptotic factors of Bcl-2 family such as Mcl-1 and Bcl-xl [45].